80.97
price up icon0.47%   +0.38
after-market  After Hours:  80.97 
loading
Bruker Corp stock is currently priced at $80.97, with a 24-hour trading volume of 450.65K. It has seen a +0.47% increased in the last 24 hours and a -12.37% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $80.69 pivot point. If it approaches the $81.39 resistance level, significant changes may occur.
Previous Close:
$80.59
Open:
$80.6
24h Volume:
450.65K
Market Cap:
$11.77B
Revenue:
$2.96B
Net Income/Loss:
$427.20M
P/E Ratio:
37.31
EPS:
2.17
Net Cash Flow:
$243.20M
1W Performance:
+4.13%
1M Performance:
-12.37%
6M Performance:
+40.28%
1Y Performance:
+4.49%
1D Range:
Value
$80.09
$81.96
52W Range:
Value
$53.79
$94.86

Bruker Corp Stock (BRKR) Company Profile

Name
Name
Bruker Corp
Name
Phone
978-663-3660
Name
Address
40 Manning Road, Billerica, MA
Name
Employee
6,200
Name
Twitter
@bruker
Name
Next Earnings Date
2024-05-02
Name
Latest SEC Filings
Name
BRKR's Discussions on Twitter

Bruker Corp Stock (BRKR) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-14-24 Upgrade JP Morgan Neutral → Overweight
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Outperform
Oct-21-22 Initiated UBS Buy
Aug-22-22 Upgrade Citigroup Neutral → Buy
Oct-15-21 Resumed Cowen Market Perform
Jun-15-21 Upgrade Cleveland Research Neutral → Buy
Feb-05-21 Downgrade Wells Fargo Overweight → Equal Weight
Dec-02-20 Initiated Goldman Sell
Nov-16-20 Upgrade Wolfe Research Underperform → Peer Perform
May-01-20 Downgrade Cleveland Research Buy → Neutral
Apr-02-20 Downgrade Wolfe Research Peer Perform → Underperform
Apr-01-20 Downgrade Needham Strong Buy → Hold
Mar-26-20 Upgrade Barclays Equal Weight → Overweight
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Initiated Stifel Hold
Sep-26-19 Upgrade BofA/Merrill Neutral → Buy
Jul-15-19 Upgrade Goldman Sell → Neutral
Jun-24-19 Reiterated Needham Strong Buy
Jun-21-19 Reiterated BofA/Merrill Neutral
May-30-19 Initiated Wolfe Research Peer Perform
May-06-19 Reiterated Needham Strong Buy
May-03-19 Upgrade SVB Leerink Mkt Perform → Outperform
May-03-19 Upgrade UBS Sell → Neutral
Apr-12-19 Upgrade Deutsche Bank Hold → Buy
Feb-12-19 Reiterated BTIG Research Buy
Jan-03-19 Initiated Needham Strong Buy
View All

Bruker Corp Stock (BRKR) Financials Data

Bruker Corp (BRKR) Revenue 2024

BRKR reported a revenue (TTM) of $2.96 billion for the quarter ending December 31, 2023, a +17.14% rise year-over-year.
loading

Bruker Corp (BRKR) Net Income 2024

BRKR net income (TTM) was $427.20 million for the quarter ending December 31, 2023, a +44.03% increase year-over-year.
loading

Bruker Corp (BRKR) Cash Flow 2024

BRKR recorded a free cash flow (TTM) of $243.20 million for the quarter ending December 31, 2023, a +67.49% increase year-over-year.
loading

Bruker Corp (BRKR) Earnings per Share 2024

BRKR earnings per share (TTM) was $2.92 for the quarter ending December 31, 2023, a +46.73% growth year-over-year.
loading

Bruker Corp Stock (BRKR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Requardt Hermann Fritz
Director
Mar 04 '24
Option Exercise
22.05
15,000
330,750
38,147
Requardt Hermann Fritz
Director
Mar 04 '24
Sale
90.06
15,000
1,350,898
23,147
Busse Falko
PRESIDENT, BIOSPIN GROUP
Feb 28 '24
Option Exercise
26.28
28,122
739,156
60,981
Busse Falko
PRESIDENT, BIOSPIN GROUP
Feb 28 '24
Sale
85.48
28,122
2,403,890
32,859
Prause Burkhard
PRES. & CEO, BRUKER BEST
Feb 22 '24
Option Exercise
43.17
5,450
235,292
32,384
Prause Burkhard
PRES. & CEO, BRUKER BEST
Feb 22 '24
Sale
83.30
15,319
1,276,073
17,065
LINTON WILLIAM A
Director
Dec 05 '23
Option Exercise
19.07
10,000
190,700
33,048
LAUKIEN FRANK H
PRESIDENT & CEO
Oct 26 '23
Option Exercise
46.14
59,523
2,746,689
38,327,911
LAUKIEN FRANK H
PRESIDENT & CEO
Aug 08 '23
Option Exercise
47.85
44,150
2,112,578
38,255,291
LAUKIEN FRANK H
PRESIDENT & CEO
Aug 08 '23
Sale
64.81
37,947
2,459,345
38,217,344
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.
medical_devices PHG
$21.07
price up icon 1.69%
medical_devices STE
$203.90
price up icon 1.17%
$309.02
price down icon 0.48%
medical_devices ZBH
$119.35
price down icon 0.33%
$124.34
price down icon 9.91%
medical_devices EW
$86.43
price down icon 1.80%
Cap:     |  Volume (24h):